Metabolic dysfunction-associated steatotic liver disease
As the prevalence of obesity increases globally, the incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) also increases in both developed and developing countries. However, the MASLD phenotype remains unclear, with many unknown reasons. Since Ludwig and others coined the te...
Saved in:
| Main Authors: | Chieh Chen, Da-Ming Liao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | Tungs’ Medical Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.4103/ETMJ.ETMJ-D-24-00019 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unmet needs of metabolic dysfunction – Associated “fatty or steatotic” liver disease
by: Yu-Ming Cheng, et al.
Published: (2025-04-01) -
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01) -
Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01) -
Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study
by: Woo-Young Shin, et al.
Published: (2025-04-01) -
Role and therapeutic perspectives of extracellular vesicles derived from liver and adipose tissue in metabolic dysfunction-associated steatotic liver disease
by: Wandi Li, et al.
Published: (2024-12-01)